About
AirNet Technology Inc. operates out-of-home advertising platforms in the People's Republic of China. The company operates a network of digital (television) TV screens on planes operated by 7 airlines; and gas station media network, as well as other outdoor media advertising platforms in gas stations. It also displays non-advertising content, such as weather, sports, comedy clips, local attractions, documentaries, commentaries, and reality shows. In addition, the company holds concession rights to install and operate Wi-Fi systems on railway administration bureaus, long-haul buses, and airlines; and operates advertising platforms, such as light boxes, billboards, and LED screens. Further, it operates CIBN-AirMedia channel to broadcast network TV programs to air travelers. The company was formerly known as AirMedia Group Inc. AirNet Technology Inc. was founded in 2005 and is headquartered in Beijing, the People's Republic of China.
Company Website : http://www.airmedia.net.cn
Address : Sky Plaza, 17th Floor, No. 46 Dongzhimenwai Street, Dongchen 100027,Beijing,CHN
Employees : 315
Fiscal Year End : December
Currency: USD
Country : USA
Technical Indicators
Beta : 2.17
Unadjusted Closing Price
Adjusted Closing Price
Share Volume
Relative Performance (Total Returns)
Compare
Relative Returns (From: To: 2021-07-24 )
Largest Industry Peers for Other
| Symbol | Name | Price(Change) | Market Cap | Price / Earning Ratio | EV/EBITDA |
|---|---|---|---|---|---|
| LGCY | Legacy Reserves Inc |
N/A |
USD61,525,874.67B | 1.10 | 5.30 |
| FTD | FTD Companies, Inc |
N/A |
USD28,725,913.80B | N/A | N/A |
| KEYW | The KeyW Holding Corporation |
N/A |
USD24,651,104.38B | 166.80 | 24.48 |
| SNHY | Helios Technologies, Inc |
N/A |
USD17,848,852.22B | 1,000,000.00 | N/A |
| QTNA | Quantenna Communications, Inc |
N/A |
USD8,997,243.52B | 175.07 | 79.98 |
| INSY | INSYS Therapeutics, Inc |
N/A |
USD4,995,459.82B | 115.90 | N/A |
| CHKE | Apex Global Brands Inc |
N/A |
USD384,202.91B | 17.30 | N/A |
| PDVW | pdvWireless, Inc |
N/A |
USD95,944.74B | N/A | N/A |
| AIPT | Predictive Oncology Inc |
N/A |
USD38,513.36B | N/A | N/A |
| SBOT | Stellar Biotechnologies, Inc |
N/A |
USD264.85B | N/A | N/A |
ETFs Containing AMCN
| Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
|---|
N/A
Market Performance
| Market Performance vs. Industry/Classification (Other) |
Market Performance vs. Exchange (NASDAQ Capital Market) | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | N/A | N/A | N/A | N/A | N/A | ||
| Trailing 12 Months | |||||||
| Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | N/A | N/A | N/A | N/A | N/A | ||
| Trailing 5 Years | |||||||
| Capital Gain | -88.50% | N/A | N/A | N/A | N/A | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -88.50% | N/A | N/A | N/A | N/A | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | -30.60% | N/A | N/A | N/A | N/A | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -30.60% | N/A | N/A | N/A | N/A | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 31.77% | N/A | N/A | N/A | N/A | ||
| Risk Adjusted Return | -96.32% | N/A | N/A | N/A | N/A | ||
| Market Capitalization | 308,457.30B | N/A | N/A | N/A | N/A | ||
| Letter Grade | Percentage | Letter Grade | Percentage | Letter Grade | Percentage |
| A+ | 97%-100% | A | 93%-96% | A- | 90%-92% |
| B+ | 87%-89% | B | 83%-86% | B- | 80%-82% |
| C+ | 77%-79% | C | 73%-76% | C- | 70%-72% |
| D+ | 67%-69% | D | 63%-66% | D- | 60%-62% |
| F | 0%-59% |
Key Financial Ratios
| Ratio vs. Industry/Classification (Other) |
Ratio vs. Market (NASDAQ Capital Market) |
||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| Market Value | |||||||
| Price / Earning Ratio | 1.00 | N/A | N/A | N/A | N/A | ||
| Price/Book Ratio | N/A | N/A | N/A | N/A | N/A | ||
| Price / Cash Flow Ratio | -15,599,135.40 | N/A | N/A | N/A | N/A | ||
| EV/EBITDA | N/A | N/A | N/A | N/A | N/A | ||
| Management Effectiveness | |||||||
| Return on Equity | N/A | N/A | N/A | N/A | N/A | ||
| Return on Invested Capital | -47.90% | N/A | N/A | N/A | N/A | ||
| Return on Assets | N/A | N/A | N/A | N/A | N/A | ||
| Debt to Equity Ratio | 5.38% | N/A | N/A | N/A | N/A | ||
| Technical Ratios | |||||||
| Short Ratio | N/A | N/A | N/A | N/A | N/A | ||
| Short Percent | N/A | N/A | N/A | N/A | N/A | ||
| Beta | 2.17 | N/A | N/A | N/A | N/A | ||
| Letter Grade | Percentage | Letter Grade | Percentage | Letter Grade | Percentage |
| A+ | 97%-100% | A | 93%-96% | A- | 90%-92% |
| B+ | 97%-89% | B | 83%-86% | B- | 80%-82% |
| C+ | 77%-79% | C | 73%-76% | C- | 70%-72% |
| D+ | 67%-69% | D | 63%-66% | D- | 60%-62% |
| F | 0%-59% |
Annual Financials (USD)
Quarterly Financials (USD)
Analyst Rating
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
No discussions yet
User / Independent Analyst Ratings
| User Name | Target Rating | Target Horizon (Months) | Target Price | User Analysis | Date | Comment |
|---|
Fundamental Analysis Breakdown
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like:
There is nothing we particularly like
What to not like:
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
